June 11, 2021

Winship Invest$ names pilot grant awardees

Photo of Winship Invest$ names pilot grant awardees

Eighteen Winship investigators will receive a total of $820,000 in funding for new cancer research projects through Winship Invest$.

Nineteen investigators will receive a total of $870,000 in funding for new cancer research projects through Winship Invest$, a peer-reviewed program designed to fund novel, innovative cancer research at Winship Cancer Institute of Emory University. The selected proposals include four projects awarded through the Prostate Cancer Research Pilot Grant program, funded in part by contributions from the Dunwoody Country Club Champions Golf Association and the club's John H. Kauffman Prostate Cancer Fundraiser.

Winship Invest$ is supported by philanthropic contributions as well as developmental funds from Winship's Cancer Center Support Grant (P30CA138292) awarded by the National Cancer Institute of the National Institutes of Health.

Winship Invest$ has two funding cycles every year. The most recent call for proposals focused on research in strategic domains, including: (1) community outreach and engagement; (2) COVID-19 and cancer; (3) early-career investigator projects; (4) Winship's four research programs; (5) and disease-site specific studies in breast cancer, melanoma, brain tumors, and prostate cancer.

This cycle's Winship Invest$ pilot grant recipients are:

  • Determinants of Response to Palladium Nanoparticles in Melanoma
    Jack Arbiser, MD, PhD
  • The Microbiome-Gut-Brain Axis and Chemotherapy-Associated Cognitive Impairment Among Breast Cancer Women (MAGIC-W)
    Jinbing Bai, PhD, RN, FAAN
  • Developing the Role of Circulating Tumor Human Papillomavirus DNA in Predicting Outcomes Following Transoral Robotic Surgery for Oropharyngeal Cancer
    James Bates, MD
  • Leveraging mHealth to improve symptom management and adherence of oral chemotherapy for women with non-metastatic triple negative breast cancer
    Ilana Graetz, PhD
  • Personalizing DNA Damage in Multiple Myeloma
    Craig Hofmeister, MD, MPH
  • Identify the mechanisms underlying triple negative breast cancer resistance to neoadjuvant therapy and to develop targeted therapy
    Xiaoxian (Bill) Li, MD, PhD
  • Community Cancer Education in Rural Underserved Georgia Counties
    Adam Marcus, PhD
  • Immune and angiogenic biomarkers for neoadjuvant cabozantinib in patients with locally advanced non-metastatic clear cell renal cell carcinoma
    Bassel Nazha, MD, MPH
  • Unraveling biomechanical mechanisms underlying immune evasion in PTPN21-mutated leukemia
    Cheng-Kui Qu, MD, PhD
  • Novel chemical probes for selective tagging of lysine methylome implicated in Lung Cancer
    Monika Raj, PhD
  • Pilot study of how low dose IL-2 in combination with immune checkpoint inhibition for advanced NSCLC
    Suresh Ramalingam, MD
  • Mechanisms of tumorigenesis and kinase inhibitor resistance in MET-mutant high-grade gliomas
    Renee Read, PhD
  • Prospective Study of Endothelial Dysfunction in Children with Transplant Associated Thrombotic Microangiopathy (TA-TMA) (PREDICT)
    Michelle Schoettler, MD
  • Data Driven Prioritization of Patients' Return to Breast Cancer Screening During the COVID-19 Pandemic
    Hari Trivedi, MD
  • People Living with HIV (PLWH) Survivorship Care Plan to Promote Cancer Screening
    Jessica Wells, PhD, RN, WHNP-BC

This cycle's Winship Invest$ Prostate Cancer Research Pilot Grant recipients are:

  • Variation in Use of Pathology Services and Genomic Testing Among Newly-Diagnosed Prostate Cancer Patients
    Christopher Filson, MD, MS
  • Stimulating immune outposts in prostate cancer to improve response to immunotherapy
    Haydn Kissick, PhD
  • Understanding Cancer-Associated Cognitive Changes in Prostate Cancer Patients
    Hui Mao, PhD
  • Salvage Proton Beam Re-Irradiation for Locally Recurrent Prostate Cancer
    Sagar Patel, MD
Cascade Link  TOP